In Drosophila melanogaster, the transcription factor Dorsal initiates dorsal-ventral (DV) patterning in the early embryo by activating or repressing genes, such as the transcription factors Twist and Snail, along the DV axis. Previous studies have shown that the microRNA gene miR-184 in the ventral portion of the embryos (the prospective mesoderm) at the early stages of Drosophila embryogenesis. In order to identify the tissue-specific enhancer that regulates miR-184 expression in the mesoderm, we generated transgenic fly lines and observed the expression of a reporter gene under the control of a potential cis-regulatory module (CRM). Our results show that this CRM is responsible for the regulation of miR-184 and furthermore, it is activated by Twist. / Biology

La classification du cancer de l'endomètre, basée sur l'histologie, conditionne la prise en charge thérapeutique alors qu'elle ne montre pas une pertinence suffisante pour prédire l'envahissement ganglionnaire. La détermination de profils d'expression biologiques corrélés au statut ganglionnaire et à d'autres facteurs pronostiques majeurs tels que les emboles apparait donc fondamentale pour mieux adapter la prise en charge. Nous avons montré, par une analyse de puce à partir des ARNs extraits de tissus sous paraffine de cancer de l'endomètre de type endométrioide, de grade 1-2, supposé limité à l'utérus, que les niveaux d'expression de cinq micro-ARNs (miR-34c-5p, -375, -184, -34c-3p, et -34b-5p) étaient plus faibles dans les tissus tumoraux avec envahissement ganglionnaire. Les niveaux d'expression de trois micro-ARNs (miR-34c-5p, -23b-5p, et -23c) étaient plus faibles dans les tissus tumoraux avec emboles lymphovasculaires. Une analyse par RT-qPCR a permis de déterminer des seuils de micro-ARNs corrélés aux facteurs pronostiques. Les patientes avec seuil d'expression du micro-ARN-184 <0,30 avaient un envahissement ganglionnaire dans 60% des cas, contre 11,5% pour les patientes avec un seuil d'expression de micro-ARN-184 >0,30, p=0,006. Les patientes avec seuil d'expression du micro-ARN-34c-5p <0,15 avaient un risque plus élevé d'avoir des emboles (92,3%) que les patientes avec un seuil d'expression de micro-ARN-34c-5p >0,15 (0,0%), p<0,001. Ces profils d'expression de micro-ARNs fournissent les bases pour de nouvelles études sur la fonction des micro-ARNs dans le cancer de l'endomètre et pourraient constituer un nouvel outil au diagnostic du statut ganglionnaire. / Current histological classification of early-stage endometrial cancer (EC) may show insufficient accuracy to precisely predict lymph node metastases leading to potential over or under treatment. Hence, additional highly sensitive and specific molecular prognostic biomarkers correlated with prognostic factors, such as nodal involvement and lymphovascular space involvement (LVSI), are needed to better adapt surgical management and adjuvant therapies. We fstudied by microarray analysis microRNA expression profiles of formalin-fixed paraffin-embedded grade 1–2 supposed early-stage endometrioid adenocarcinomas specimen. The expression levels of 5 microRNAs (miR-34c-5p, -375, -184, -34c-3p, et -34b-5p) were lower in the EC with positive nodal status compared to those with negative nodal status. The expression levels of 3 microRNAs (miR-34c-5p, -23b-5p, et -23c) were lower in the EC with positive LVSI compared to those with negative LVSI. A quantitative reverse transcriptase–PCR assay was used to determine micro-RNAs thresholds correlated with prognostic factors. Women with a microRNA-184-fold change <0.30 were more likely to have positive lymph node (n=6; 60.0%) compared with those with a microRNA-184-fold change >0.30 (n=3; 11.5%), p=0.006. Women with a microRNA-34c-5p fold change <0.15 were more likely to have positive LVSI status (n=12; 92.3%) compared with those with a microRNA-34c-5p fold change >0.15 (n=0; 0.0%), p<0.001. These microRNA expression profiles may provide a basis for further studies of the micro-RNA function in endometrioid adenocarcinoma, and be used as a diagnostic tool.

Introdução: A epilepsia pode ser considerada uma desordem neurológica causada pela anormalidade da transmissão de impulsos nervosos, devido ao aumento da excitação nervosa e/ou diminuição da sua inibição. Dentre as síndromes epilépticas, destaca-se a Epilepsia do Lobo Temporal Mesial (ELTM) devido a sua alta prevalência e refratariedade ao tratamento medicamentoso. Com intuito de implementar novas possibilidades de tratamento torna-se necessário uma maior compreensão das bases moleculares da ELTM. Dentro desta perspectiva, destacam-se os microRNAs, que possuem papel regulatório nas células, inclusive as do Sistema Nervoso Central. Com base em dados da literatura e num experimento de microarray, realizado no laboratório de Biologia Molecular do Departamento de Cirurgia e Anatomia da Faculdade de Medicina de Ribeirão Preto, foram escolhidos 3 dos 10 microRNAs, cujos alvos preditos estão relacionados à epileptogênese e que se apresentam diferencialmente expressos em hipocampos de pacientes com ELTM. Objetivos: avaliar a expressão diferencial de três microRNAs de interesse em hipocampos de pacientes operados por ELTM refratária ao tratamento clínico a fim de correlacionar os resultados em relação aos controles das crises epilépticas após a cirurgia. Metodologia: Foram utilizadas 15 amostras de hipocampo de pacientes com ELTM classificados como Engel I (boa evolução - nenhuma ou poucas crises convulsivas após lobectomia temporal parcial) e 15 amostras de hipocampos de pacientes classificados como Engel III/IV (má evolução - sem melhora evidente após tratamento cirúrgico). Como controles, foram utilizadas 10 amostras de hipocampo de pacientes sem doenças neurológicas, obtidas de necropsias do Serviço de Patologia do Hospital das Clínicas de Ribeirão Preto (HCFMRP). Por meio de técnica de PCR quantitativo em tempo real (RT-qPCR) foram realizadas as avaliações das expressões diferenciais dos seguintes microRNAs: miR-184, miR-190a-5p e miR-493-3p. Resultados: Em relação aos controles, o miR-184 e o miR190a-5p apresentaram-se, respectivamente, com redução significativa (p = 0,001) e com tendência a baixa expressão (p = 0,24) nos hipocampos de pacientes com ELTM. No que se refere ao controle das crises, o miR-184 apresentou-se significativamente mais expresso nos hipocampos de pacientes com pior evolução (Engel III/IV vs Engel I, p = 0,003). A expressão do miR-493-3p não se correlacionou com o controle de crises com significância estatística. Conclusão: Dentro os microRNAs avaliados, a expressão do miR-184, que possui importante papel na regulação de componentes celulares relacionados a apoptose e morte celular, correlacionou-se inversamente com o controle das crises após cirurgia (mais expresso em pacientes com má evolução) tornando-se potencial biomarcador e com valor preditivo / Introduction: Epilepsy is a neurological disorder caused by nerve impulse transmission abnormalities, by increasing nerve excitation and/or decreasing nerve inhibition. Among the epileptic syndromes, one of the most important ones is Mesial Temporal Lobe Epilepsy (MTLE) due to its high prevalence and resistance to drug treatment. A greater understanding of the epilepsy molecular basis is necessary aiming to implement new treatments possibilities. Within this field of study, it is possible to highlight the microRNA molecules, which have a regulatory role in cell regulation including in the Central Nervous System (CNS). Based on literature data and in an microarray experiment, performed in the Anatomy and Surgery Departament Molecular Biology laboratory of the Ribeirao Preto Medical School, we have chosen three out of ten microRNAs, with predicted targets related to epileptogenesis and that presented themselves differencially expressed in patients hippocampus with MTLE. Objective: To evaluate three microRNAs of interest which were differentially expressed in the hippocampus of MTLE drug-resistant operated patients in order to correlate the results with the clinical evolution based on the seizures control after surgery. Methodology: Fifteen hippocampus samples from patients with MTLE classified as Engel I (good evolution - without seizures or few seizures after surgical resection) and 15 samples from patients classified as Engel III/IV (bad evolution - no evident improvement after surgery) were used in this study. In the control group, we used ten samples of hippocampus fragments from patients without neurological diseases, that were obtained from the Ribeirao Preto Clinical Hospital Pathology and Legal Medicine Service. The differential expression validation from microRNAs-184, -190a-5p and -493-3p were performed by quantitative real time PCR (RT-qPCR) technique. Results: Regarding the controls, miR-184 and miR- 190a-5p showed, respectively, a significant expression reduction (p=0,001) and a decreased expression tendency (p=0,24) in MTLE patients. If we consider seizure control, miR-184 presented itself significantly upregulated in bad evolution hippocampus patients (Engel III/IV vs Engel I, p=0,003). miR-493-3p did not show expression differences with statistical significance. Conclusions: After evaluating the expression of these microRNAs, it was possible to conclude that microRNA-184, which regulates cellular death and apoptosis related components, was the best molecule that could differentiate the patients regarding seizure control after surgery, and that fact makes this microRNA a potential biomarker with predictive value

Introdução: A epilepsia pode ser considerada uma desordem neurológica causada pela anormalidade da transmissão de impulsos nervosos, devido ao aumento da excitação nervosa e/ou diminuição da sua inibição. Dentre as síndromes epilépticas, destaca-se a Epilepsia do Lobo Temporal Mesial (ELTM) devido a sua alta prevalência e refratariedade ao tratamento medicamentoso. Com intuito de implementar novas possibilidades de tratamento torna-se necessário uma maior compreensão das bases moleculares da ELTM. Dentro desta perspectiva, destacam-se os microRNAs, que possuem papel regulatório nas células, inclusive as do Sistema Nervoso Central. Com base em dados da literatura e num experimento de microarray, realizado no laboratório de Biologia Molecular do Departamento de Cirurgia e Anatomia da Faculdade de Medicina de Ribeirão Preto, foram escolhidos 3 dos 10 microRNAs, cujos alvos preditos estão relacionados à epileptogênese e que se apresentam diferencialmente expressos em hipocampos de pacientes com ELTM. Objetivos: avaliar a expressão diferencial de três microRNAs de interesse em hipocampos de pacientes operados por ELTM refratária ao tratamento clínico a fim de correlacionar os resultados em relação aos controles das crises epilépticas após a cirurgia. Metodologia: Foram utilizadas 15 amostras de hipocampo de pacientes com ELTM classificados como Engel I (boa evolução - nenhuma ou poucas crises convulsivas após lobectomia temporal parcial) e 15 amostras de hipocampos de pacientes classificados como Engel III/IV (má evolução - sem melhora evidente após tratamento cirúrgico). Como controles, foram utilizadas 10 amostras de hipocampo de pacientes sem doenças neurológicas, obtidas de necropsias do Serviço de Patologia do Hospital das Clínicas de Ribeirão Preto (HCFMRP). Por meio de técnica de PCR quantitativo em tempo real (RT-qPCR) foram realizadas as avaliações das expressões diferenciais dos seguintes microRNAs: miR-184, miR-190a-5p e miR-493-3p. Resultados: Em relação aos controles, o miR-184 e o miR190a-5p apresentaram-se, respectivamente, com redução significativa (p = 0,001) e com tendência a baixa expressão (p = 0,24) nos hipocampos de pacientes com ELTM. No que se refere ao controle das crises, o miR-184 apresentou-se significativamente mais expresso nos hipocampos de pacientes com pior evolução (Engel III/IV vs Engel I, p = 0,003). A expressão do miR-493-3p não se correlacionou com o controle de crises com significância estatística. Conclusão: Dentro os microRNAs avaliados, a expressão do miR-184, que possui importante papel na regulação de componentes celulares relacionados a apoptose e morte celular, correlacionou-se inversamente com o controle das crises após cirurgia (mais expresso em pacientes com má evolução) tornando-se potencial biomarcador e com valor preditivo / Introduction: Epilepsy is a neurological disorder caused by nerve impulse transmission abnormalities, by increasing nerve excitation and/or decreasing nerve inhibition. Among the epileptic syndromes, one of the most important ones is Mesial Temporal Lobe Epilepsy (MTLE) due to its high prevalence and resistance to drug treatment. A greater understanding of the epilepsy molecular basis is necessary aiming to implement new treatments possibilities. Within this field of study, it is possible to highlight the microRNA molecules, which have a regulatory role in cell regulation including in the Central Nervous System (CNS). Based on literature data and in an microarray experiment, performed in the Anatomy and Surgery Departament Molecular Biology laboratory of the Ribeirao Preto Medical School, we have chosen three out of ten microRNAs, with predicted targets related to epileptogenesis and that presented themselves differencially expressed in patients hippocampus with MTLE. Objective: To evaluate three microRNAs of interest which were differentially expressed in the hippocampus of MTLE drug-resistant operated patients in order to correlate the results with the clinical evolution based on the seizures control after surgery. Methodology: Fifteen hippocampus samples from patients with MTLE classified as Engel I (good evolution - without seizures or few seizures after surgical resection) and 15 samples from patients classified as Engel III/IV (bad evolution - no evident improvement after surgery) were used in this study. In the control group, we used ten samples of hippocampus fragments from patients without neurological diseases, that were obtained from the Ribeirao Preto Clinical Hospital Pathology and Legal Medicine Service. The differential expression validation from microRNAs-184, -190a-5p and -493-3p were performed by quantitative real time PCR (RT-qPCR) technique. Results: Regarding the controls, miR-184 and miR- 190a-5p showed, respectively, a significant expression reduction (p=0,001) and a decreased expression tendency (p=0,24) in MTLE patients. If we consider seizure control, miR-184 presented itself significantly upregulated in bad evolution hippocampus patients (Engel III/IV vs Engel I, p=0,003). miR-493-3p did not show expression differences with statistical significance. Conclusions: After evaluating the expression of these microRNAs, it was possible to conclude that microRNA-184, which regulates cellular death and apoptosis related components, was the best molecule that could differentiate the patients regarding seizure control after surgery, and that fact makes this microRNA a potential biomarker with predictive value

No description available.